<p>Effect of <i>FYGL</i> and metformin on normal and db/db diabetic mice for 8 weeks, Results are expressed as mean ± S.E.M., n = 10, (A) Body weight changes (B) Fast blood glucose (FBG).</p
<p>Fasting blood glucose and body weight were measured before THSG treatment and after THSG was admi...
<p>The body weight (A) and blood glucose levels (B) of C57BL/6 mice were measured once a week. Blood...
<p>A. Blood glucose levels of control and diabetic mice are shown as a function of time after the in...
<p>A: Blood glucose levels and B: plasma insulin concentrations during the 8-week treatment period (...
<p>Male C57BL6/J mice were fed with either a standard chow diet (lean) or a high-fat diet (obese) du...
<p>The animals were dosed intraperitoneally once daily with metformin (closed triangles) or twice da...
<p>Results are expressed as mean ± S.E.M., n = 10.</p>*<p>p<0.05 as compared to diabetic control and...
Background: Metformin is the common first-line medication for treating type 2 diabetes. Besides its ...
<p>Mice [except saline group] were injected with 1,2-dimethylhydrazine (DMH) weekly for 15 week to i...
<p>Male C57BL/6J mice, at 5–6 weeks of age, were fed a high-fat diet (HFD) and treated with metformi...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>Data represent the means ± SEM for 5–10 mice.</p>***<p>p<0.001 compared with lean group;</p>#<p>p...
<p>A: Blood glucose levels and B: plasma insulin concentrations during the 8-week treatment period (...
(A) The glucose concentration curves in the glucose tolerance test. (B) The AUC0-120 values for the ...
Hepatic insulin resistance and increased gluconeogenesis are known therapeutic targets of metformin,...
<p>Fasting blood glucose and body weight were measured before THSG treatment and after THSG was admi...
<p>The body weight (A) and blood glucose levels (B) of C57BL/6 mice were measured once a week. Blood...
<p>A. Blood glucose levels of control and diabetic mice are shown as a function of time after the in...
<p>A: Blood glucose levels and B: plasma insulin concentrations during the 8-week treatment period (...
<p>Male C57BL6/J mice were fed with either a standard chow diet (lean) or a high-fat diet (obese) du...
<p>The animals were dosed intraperitoneally once daily with metformin (closed triangles) or twice da...
<p>Results are expressed as mean ± S.E.M., n = 10.</p>*<p>p<0.05 as compared to diabetic control and...
Background: Metformin is the common first-line medication for treating type 2 diabetes. Besides its ...
<p>Mice [except saline group] were injected with 1,2-dimethylhydrazine (DMH) weekly for 15 week to i...
<p>Male C57BL/6J mice, at 5–6 weeks of age, were fed a high-fat diet (HFD) and treated with metformi...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>Data represent the means ± SEM for 5–10 mice.</p>***<p>p<0.001 compared with lean group;</p>#<p>p...
<p>A: Blood glucose levels and B: plasma insulin concentrations during the 8-week treatment period (...
(A) The glucose concentration curves in the glucose tolerance test. (B) The AUC0-120 values for the ...
Hepatic insulin resistance and increased gluconeogenesis are known therapeutic targets of metformin,...
<p>Fasting blood glucose and body weight were measured before THSG treatment and after THSG was admi...
<p>The body weight (A) and blood glucose levels (B) of C57BL/6 mice were measured once a week. Blood...
<p>A. Blood glucose levels of control and diabetic mice are shown as a function of time after the in...
DOI
Add to ORKG